Abingdon Health subsidiary secures significant contract
Lateral flow contract research and manufacturing specialist Abingdon Health announced on Wednesday that its subsidiary CS Lifesciences has secured a significant contract worth over £0.5m.
Abingdon Health
08 January 2025 15:01:36
Source: Sharecast
The AIM-traded firm said the agreement, with a major global diagnostics company, involved work on quality management systems and regulatory approvals.
It said the contract would start in March and run for 12 months, generating steady revenue throughout the period.
It marked a key milestone for CS Lifesciences, which Abingdon Health acquired in August to enhance its capabilities in supporting customers across the in-vitro diagnostics (IVD) and medical device sectors.
The board said the acquisition had allowed Abingdon to broaden its service offerings, helping clients navigate compliance requirements and take their products from concept to market success.
“This contract illustrates one aspect of Abingdon's service offering in the medical diagnostic sector and to the wider med-tech industry,” said Abingdon chief executive officer Chris Yates.
“Our full CDMO service, offering services to an international customer base, has been enhanced by our recent acquisition of CS Lifesciences, and I congratulate Edwin and the team on this contract win with a major diagnostics company.”
At 1315 GMT, shares in Abingdon Health were up 6.25% at 8.5p.
Reporting by Josh White for Sharecast.com.
N/A
Isin:
N/A
Exchange: N/A
Sell:
N/A
Buy:
N/A
Change:
Date:
Prices delayed by at least 15 minutes
Compare our accounts
If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.
Lloyds Bank is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.
Important legal information
Lloyds and Lloyds Bank are trading names of Halifax Share Dealing Limited. The Lloyds Bank Direct Investments Service is operated by Halifax Share Dealing Limited. Registered Office: Trinity Road, Halifax, West Yorkshire, HX1 2RG. Registered in England and Wales no. 3195646. Halifax Share Dealing Limited is authorised and regulated by the Financial Conduct Authority, 12 Endeavour Square, London, E20 1JN under registration number 183332. A Member of the London Stock Exchange and an HM Revenue & Customs Approved ISA Manager.
The information contained on this website and in the tools, data, prices, news, charts, fundamentals and other content made available through it is provided by Communify Europe Limited, unless expressly stated otherwise.
The information is provided for informational purposes only. It does not constitute investment advice, a personal recommendation, investment research, a research recommendation, an invitation or inducement to engage in investment activity, or a recommendation to buy, sell or hold any share, company, fund, investment vehicle or other financial instrument. Communify Europe Limited does not assess the suitability or appropriateness of any investment for any user.
The information is based on sources that Communify Europe Limited considers reliable. However, Communify Europe Limited does not guarantee that the information is accurate, complete, current, uninterrupted, secure or error-free. Prices, quotes and trades may be delayed by at least fifteen minutes unless expressly stated to be provided in real time.
Past performance is not an indicator of future performance. Communify Europe Limited does not guarantee the return of any investment or the performance of any security, company, investment vehicle, index, underlying asset or market. The value of investments may rise or fall, and investors may lose all or part of the amount invested.
To the extent permitted by applicable law, Communify Europe Limited will not be liable for any loss or damage arising from use of the information contained on this website. Nothing in this notice excludes or limits liability for fraud, death or personal injury caused by negligence, breach of the duty to provide services with reasonable care and skill, or any other liability that cannot be excluded or limited under applicable law. Terms and conditions apply.
Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.
